Frequently Asked Questions.

Molecular Ideas was founded to share the stories of under-the-radar startups in the pharmaceutical, medical device, diagnostic, and medtech spaces. We work with founders working to address critical unmet needs by ensuring their stories are told, and told well, through our article columns and expertise.

Our Startup Showcase column highlights the stories of founders of under-the-radar companies with innovative technologies. We discuss your company’s origin story, how you are attempting to address a critical unmet need in the life sciences, and some of the challenges that you and your team have faced. We want to provide coverage that opens up opportunities for investment and partnership inquiries while faithfully representing your technology and story.

We are proud to have a readership comprised of startup founders, investors, academics, students, news writers, and industry leaders interested in learning about the state of early-stage life science entrepreneurship.

We would love to discuss your company, technology, and entrepreneurial journey. Please feel free to reach out to us via the Contact Us form.

We conduct interviews with founders (and/or their colleagues) to learn more about their story before synthesizing a story that contextualizes your innovations with industry investments, patient perspectives, and the technological space. From there, founders will have a chance to review the story before it is posted at a pre-determined time. We try to keep interviews fun and thoughtful while recognizing the importance of your technology and the people it means to serve. Transcripts of the discussion are taken for note-taking purposes and are kept confidential.

We understand that you may be hesitant to share about your company’s origin story, technology, and/or current challenges. We want to provide coverage that opens up opportunities for investment and partnership inquiries while faithfully representing your technology and story. If you are interested in exploring being featured at some point, we encourage you to reach out via the Contact Us form.

Managing cash burn is critical to any startup’s success. We ask for a small stipend in order to cover costs for relevant resources and research necessary to production and upkeep of our platform. However, we can be flexible based on your available funds and budget – please feel free to reach out with any questions via the Contact Us form.

Our primary focus and body of expertise is in the life sciences. However, we regularly work with early-stage startups in many industries (including fintech, edtech, engineering & construction, etc.) to keep on top of the latest trends and challenges that entrepreneurs everywhere face each day. Please feel free to reach out with any questions via the Contact Us form.

Our Entrepreneurial Excellence column explores challenges that founders, employees, and partners often face. These range from general challenges faced by entrepreneurs in all industries, to those specific to the life sciences (e.g., risk management, regulatory strategy, etc.). If you have any ideas about challenges you or other entrepreneurs face, please feel free to reach out via the Contact Us form.

Unfortunately, we are not equipped to provide capital to companies. However, our network includes several prominent angel and venture capital investment groups.

We send out a summary of our latest Startup Showcase and Entrepreneurial Excellence articles, as well as other relevant news and offerings. You can sign up via the form on our homepage or the Contact Us form. Stay tuned!

We provide a wide range of consulting services to companies upon request, including narrative crafting, strategic marketing, branding, product planning, financial modeling, and more. Please feel free to contact us to schedule a brief discussion about your company’s specific challenges and budgets. We can be flexible to meet your company’s needs.

Absolutely – we look forward to hearing from you. Please use the Contact Us form below and we will get back to you as soon as possible.